CGU’s Healthy Aging Research Center Focuses on Degenerative Diseases
Affecting Elderly Human Health
MILFORD, Mass.--(BUSINESS WIRE)--Jun. 11, 2015--
At a recent ceremony at Taipei’s Chang
Gung University (CGU), Waters Corporation welcomed the University’s
Healthy Aging Research Center as a Waters Centers of Innovation (COI)
Program partner - the first in Taiwan.
This Smart News Release features multimedia. View the full release here:
In celebration of its selection as a Waters Center of Innovation, Chang Gung University (CGU) hosted a ceremony in recognition of the research of Prof. Daniel Chiu. Pictured are (from left to right) Prof. Chih-Wei Yang, MD, Dean of College of Medicine, CGU; Prof. Chiu; Prof. Ta-Sen Yeh, MD, Chair, Board of Chang Gung Medical Research Review and Evaluation; Prof. Ming-Shi Shiao, Ph.D, Director of Metabolomic Core, CGU; Dean Yu, General Manager of Waters in Taiwan; Eric Fotheringham, Director - Waters Centers of Innovation Program; Dr. Gigin Lin, MD, Ph.D, Physician Scientist, Staff Radiologist, Chang Gung Memorial Hospital. (Photo: Business Wire)
The Waters COI Program recognizes analytical scientists facilitating
breakthroughs in health and life science research, food safety,
environmental protection, sports medicine and other areas through the
use of liquid chromatography and mass spectrometry.
Led by Dr.
Daniel Tsun-Yee Chiu, Ph.D., Dean of Research & Development, and
director of CGU’s Healthy
Aging Research Center, the Center focuses on the implementation of
advanced analytical science to answer key questions on the mechanisms of
disease that affect human health, particularly in the elderly. Dr. Chiu
has a special interest in the effects of oxidative stress on cellular
function and establishing reference laboratories to assess oxidative
stress and antioxidant capacity in health and in diseases. He is
currently the president of the Society of Free Radical Research-Asia and
he has published over 140 scientific articles along this area.
Dr. Chiu expressed his deep gratitude that CGU’s Healthy Aging Research
Center has been selected to become a Waters Center of Innovation partner.
“We are truly honored to become Waters Corporation’s COI partner in
Taiwan. I am confident that the research conducted with the assistance
of Waters’ technology will lead to breakthroughs that will greatly
advance the study of various degenerative diseases and their impact on
human health. I would like to once more extend our thanks to Waters for
their recognition of our research,” said Dr. Chiu.
Attending the ceremony was Dean Yu, General Manager of Waters Taiwan,
who extended his congratulations on behalf of Waters to Dr. Chiu and his
“Dr. Chiu and his colleague, Professor Ming-Shi Shiao have been
advocates, technical advisors, and pioneers in the field of
metabolomics, metabolite I.D. and profiling in Taiwan for many years.
Their considerable influence within CGU, as well as other major
Taiwanese and international institutes is well deserved. On behalf of
all Waters employees, we are excited that Chiu’s team is now a Waters
COI partner," said Yu.
Currently, the Healthy Aging Research Center at CGU is equipped with Waters®
Synapt® HDMS systems, ACQUITY
UPLC® systems, including an ACQUITY®
UPC2 system, and Xevo®
The Centers of Innovation Program ceremony was held in conjunction with
a symposium, “Metabolomics from Bench to Bedside” which was co-organized
by Chang Gung University and Waters Corporation and featured
presentations by Professor Jeremy Nicholson, Imperial College London;
Professor David Wishart, University of Alberta; Professor Kumar Sharma,
University of California San Diego; Professor David Herold and Professor
Liang Li, University of Alberta.
is the study of molecules known as metabolites that are produced by
living organisms as the result of biological processes. Metabolites have
been used as biomarkers for decades. The presence of sugar in urine as a
diagnostic test for diabetes is one of the oldest examples. Mass
spectrometry is an extremely sensitive means of studying the full
array of metabolites produced by an organism. From a few microliters of
blood or extract scientists are beginning to learn a great deal about
the biological underpinnings of disease processes, the response of an
organism like a plant to an environmental stress or the response of a
test subject to the administration of a drug simply by measuring the
type and concentration of metabolites present.
About Chang Gung University
Chang Gung University (CGU) was first established in April 1987 as the
Chang Gung Medical College and later renamed Chang Gung University
in July 1997. Currently, the university has approximately 600 full-time
faculty members, and has more than 7,400 students enrolled. CGU has been
striving for excellence in both instruction and research area. In order
to educate and shape students to be “diligent, perseverant, frugal, and
trustworthy” and well-versed in both theory and practice, CGU has
instituted an extracurricular practicum system and been working closely
with Chang Gung Memorial Hospital, the Formosa Plastics Group, and other
institutions to conduct work-study programs as well as practical
training. In taking advantage of Formosa Plastics Group's abundant
manufacturing and medical service resources, CGU aims to be a first-rate
internationally renowned university that prepares high standard
professional talents in the fields of medical sciences, engineering, and
management. In 2014, CGU has been selected as top 500 Universities in
Academic Ranking of World Universities (ARWU) for the 7th
consecutive year and CGU is ranked 5th among all universities
About Waters Centers of Innovation Program
Centers of Innovation Program recognizes and supports the efforts of
scientists facilitating breakthroughs in health and life science
research, food safety and food science, environmental protection, sports
medicine and many other areas. Waters provides scientists and their
institutions in the Program with early access to pre-commercialized
novel technology that may lead to scientific breakthroughs and
jump-start a research project. In other instances, collaborative efforts
between Waters experts applications scientists and Program participants
have accelerated research in important ways.
In addition to Dr. Chiu, other researchers and research centers
recognized by the Waters Centers of Innovation Program include: Professor
Ganesh Anand, National University of Singapore; Professor
Luiz Claudio Cameron, UniRio, Brazil; Professor
David Clemmer, Indiana University; Professor
Daniel Tsun-Yee Chiu, Chang Gung University; Dr.
Joseph Dalluge, University of Minnesota; Dr.
Petur Weihe Dalsgaard, University of Copenhagen; Professor
Marcos Eberlin, University of Campinas, Brazil; Prof.
Chris Elliott, Queen’s University Belfast; Professor
John Engen, Northeastern University; Professor
Albert J. Fornace, Jr., Georgetown Lombardi Comprehensive Cancer
David Goodlett and Dr.
Maureen Kane, University of Maryland School of Pharmacy; Professor
De-an Guo, Shanghai
Institute of Materia Medica; Dr.
Frank Gonzalez, National Cancer Institute; Dr.
Carlo R. Largiadèr, Inselspital University Hospital; Professor
Julie Leary of the University of California – Davis; Professor
Amit Kumar Mandal, St. John’s Research Institute, Bangalore, India; Professor
John McLean, Vanderbilt University; Professor
Arthur Moseley, Duke University; Professor
Jeremy Nicholson, Imperial College London; Dr.
Devin Peterson, University of Minnesota; Assistant
Jessica Prenni, Colorado State University; Dr. Serge Rezzi, Nestle
Institute of Health Sciences; Dr.
Ryan Rogers, Future Fuels Institute, Florida State University; Professor
Pauline Rudd, National Institute for Bioprocessing Research and
James Scrivens, University of Warwick; Professor
Vladimir Shulaev, University of North Texas; Dr.
Norman Smith, Kings College London; Professor
Sarah Trimpin, Wayne State University; Professor
Bert van Bavel, Örebro University, Örebro, Sweden; Caroline West and
Eric Lesselier, University
of Orleans, Orleans, France; and Professor
Vicki Wysocki, Ohio State University.
About Waters Corporation (www.waters.com)
For more than 50 years, Waters Corporation (NYSE:WAT) has created
business advantages for laboratory-dependent organizations by delivering
practical and sustainable innovation to enable significant advancements
in such areas as healthcare delivery, environmental management, food
safety, water quality, consumer products, and high value-added chemicals
Pioneering a connected portfolio of separations science, laboratory
information management, mass spectrometry and thermal analysis, Waters
technology breakthroughs and laboratory solutions provide an enduring
platform for customer success.
Waters, Synapt, XEVO, ACQUITY UPLC, and ACQUITY are trademarks of Waters
View source version on businesswire.com: http://www.businesswire.com/news/home/20150611005871/en/
Source: Waters Corporation
Brian Murphy, 508-482-2614